Status Migrainosus - Differentiating Between Responders and Non-responders

NCT03066544 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: Bupivacaine
DRUG: Naratriptan Pill
DRUG: Dexamethasone
DRUG: Ketorolac

Sponsor

Hartford HealthCare